iFerex 150 By ZIKS Overview & Drug Interactions
Check For Interactions With iFerex 150
Supplement: iFerex 150 by ZIKS
iFerex 150 Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Iron
| Ingredient Group | Iron |
|---|---|
| Category | mineral |
-
Polysaccharide Iron Complex
Ingredient Group Iron Category non-nutrient/non-botanical
Drugs that interact with iFerex 150 by ZIKS
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
1 Capsule(s)
|
| Maximum serving Sizes: |
1 Capsule(s)
|
| Servings per container | 100 |
| UPC/BARCODE | 363044203012 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Iron |
150 mg
|
Iron |
833%
|
| Polysaccharide Iron Complex |
326.1 mg
|
Iron |
|
| Other Ingredients: |
Gelatin
Microcrystalline Cellulose
Magnesium Stearate
Titanium Dioxide
FDA/E172 Red Iron Oxide
FD&C Yellow #10
FDA/E172 Black Iron Oxide
FD&C Red #28
FD&C Red #40
FD&C Blue #1
|
|---|
Label Statments:
| Formulation |
- Description: iFerex 150 capsules is a brown and orange capsule with marking "ziks 0203". It is a product of ferric iron complexed to a low molecular weight polysaccharide.
- Indications and Usage: iFerex 150 is indicated for the prevention and treatment of iron deficiency anemia and/or nutritional megaloblastic anemias.
|
|---|---|
| Precautions |
- Contraindications: iFerex 150 is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications to iron therapy.
- Adverse Events: You should call your doctor for medical advice about adverse events. To report a serious adverse event contact Nnodum Pharmaceuticals. 483 Northland Blvd., Cincinnati, OH, 45240.
- Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control immediately.
Keep this product and all drugs out of reach of children.
- Dispense in a tight, light-resistant container with a child resistant closure.
|
| Suggested/Recommended/Usage/Directions |
- Dosage and Administration: Adults: 1 capsule daily or as directed by your physician.
|
| FDA Statement of Identity |
- Iron Supplement
|
| Storage |
- Storage: Store at 20 degrees C - 25 degrees C (58 degrees - 77 degrees F): excursions permitted to 15 degrees C - 30 degrees C (59 degrees - 86 degrees F).
|
| General Statements |
- 63044-0203-01
|
Brand Information
See all products by this brand
| Distributed by | |
|---|---|
| Name | Nnodum Pharmaceuticals |
| City | Cincinnati |
| State | OH |
| ZipCode | 45240 |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.